C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 1, 2000, Pages 198-203

  Margaglione, Maurizio ^a   Cappucci, Giuseppe ^a   Colaizzo, Donatella ^a   Vecchione, Gennaro ^a   Grandone, Elvira ^a   Di Minno, Giovanni ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Myocardial infarction; Risk factors; Thrombosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033978020     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.1.198     Document Type: Article

References (45)

1. Hopkins PN, Williams RR, Kuida H, Stults BM, Hunt SC, Barlow GK, Ash KO. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol. 1988;62: 703-707.
2. Roncaglioni MC, Santoro L D'Avanzo B, Negri E, Nobili A, Ledda A, Pietropaolo F, Franzosi MG, La Vecchia C, Feruglio GA, Maseri A, on behalf of GISSI-EFRIM investigators. Role of family history in patients with myocardial infarction: an Italian case-control study: GISSI-EFRIM investigators. Circulation. 1992;85:2065-2072.
3. Rosseneu M, Cambien F, Vinaimont N, Nicaud V, De Backer G. Biomarkers of dietary fat composition in young adults with a parental history of premature coronary heart disease compared with controls. Atherosclerosis. 1994;108:127-136.
4. Klausen IC, Beisiegel U, Menzel HJ, Rosseneu M, Nicaud V, Faergeman O. Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction: the EARS study. Anterioscler Thromb Vasc Biol. 1995;15:1001-1008.
5. Wang XL, Tam C, McCredie RM, Wilken DEL. Determinants of severity of coronary heart disease in Australian men and women. Circulation. 1994;89:1974-1981.
6. Tiret L, Kee F, Poirer O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Amouyel P, Cambien F. Deletion polymorphism in the angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993;341:991-992.
7. Badenhop RF, Wang XL, Wilken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation. 1995;91:1655-1658.
8. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol. 1998;18:526-534.
9. Margaglione M, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, Grandone E, Pennelli O, Di Minno G. Plasminogen activator inhibitor-1 (PAI-1) gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol. 1998; 18:152-156.
10. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic values of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
11. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
13. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312:1061-1065.
14. Kannell WB. Bishop lecture: contribution of the Framingham study to preventive cardiology. J Am Coll Cardiol. 1990;15:206-211.
15. Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, Giordano M, Grilli M, Simone P, Fusilli S, Panico S, Mancini M. Raised plasma fibrinogen concentrations in subjects attending a metabolic ward: relation to family history and vascular risk factors. Thromb Haemost. 1995;73:579-583.
16. Joint National Committee. The fifth report of the Joint National Committee on the detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1993;153:154-183.
17. The Expert Committee on the diagnosis and classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197.
18. Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, Grilli M, Simone P, Panico S, Mancini M. Abnormally high circulating levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb. 1994;14:1741-1745.
19. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost. 1991;65:487-490.
20. Margaglione M, Grandone E, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, D'Addedda M, Di Minno G. An alternative method for PAI-I promoter polymorphism (4G/5G) typing. Thromb Haemost. 1997; 77:605-606.
21. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptyl carboxypeptidase 1). Nucleic Acids Res. 1992; 20:1433.
22. Margaglione M, Celentano E, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Panico S, Mancini FP, Di Minno G. Deletion polymorphism of the angiotensin converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol. 1996;16: 304-309.
23. Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of the PAI-1 and the angiotensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol. 1997; 17:2082-2087.
24. Zingone A, Dominijanni A, Mele E, Marasco O, Melina F, Minichella P, Quaresima B, Tiano MT, Gnasso A, Puija A, Perrotti N. Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet. 1994;94:207-209.
25. -455→A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease: a study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest. 1997;99:3034-3039
26. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J. Biol Chem. 1993;268:10739-10745.
27. Mansfield MW, Stickland MH, Grant PJ. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non insulin-dependent diabetes mellitus. Thromb Haemost. 1995;74:842-847.
28. de Faire U. Ischemic heart disease in death discordant twins: a study in 205 male and female pairs. Acta Med Scand Suppl. 1974;568:1-109.
29. Berg K. Twin research in coronary heart disease. In: Parisi GL, Nance WL, eds. Twin Research 3: Epidemiological and Clinical Studies. New York, NY: Alan R Liss; 1981:117-130.
30. Humphries SE. The genetic contribution to the risk of thrombosis and cardiovascular disease. Trends Cardiovasc Med. 1994;4:8-17.
31. Goldbourt U, Neufeld HN. Genetic aspect of arteriosclerosis. Arteriosclerosis. 1986;6:357-377.
32. Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L, on behalf of the European Atherosclerosis Research Study (EARS) group. European atherosclerosis research study: genotype at the fibrinogen locus (G-455-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol. 1995;15:96-104.
33. Førde OH, Thelle DS. The Tromsø Heart Study: risk factors for coronary heart disease related to the occurrence of myocardial infarction in first-degree relatives. Ann J Epidemiol. 1977;105:192-199.
34. Silberberg J, Alexander H, Wlodarczyk J, Basta M, Hensley M, Hughes J, Ray C. Accuracy of reported family history of heart disease: impact of 'don't know' responses. Aust N Z J Med. 1994;24:386-389.
35. Napier JA, Metzner H, Johnson BC. Limitation of morbidity and mortality data obtained from family histories: a report from the Tecumseh community health study. Am J Public Health. 1972;62:30-35.
36. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull WHO. 1962;27:645-658.
37. Haverkate F. Thrombosis and disabilities. In: Baya C, ed. Advances in Medical Biology. Amsterdam, Netherlands: IOS Press; 1994:81-103.
38. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
39. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
40. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA. 1990;263:2204-2207.
41. Saikku P, Leinonen M, Tenkanen L, Linnanmanki E, Ekman MR, Manninen V, Manttari M, Frick ME, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116:273-278.
42. Di Minno G, Grandone E, Margaglione M. Clinical relevance of polymorphic markers of arterial thrombosis. Thromb Haemost. 1997;78: 462-466.
43. Adler NE, Boyce T, Chesney MA, Cohen S, Folkman S, Kahn RL, Syme SL. Socioeconomic status and health: the challenge of the gradient; Am Psychol. 1994;49:15-24.
44. Weinberg R, Webber LS, Berenson GS. Hereditary and environmental influence on cardiovascular risk factors for children: the Bogalusa Heart Study. Am J Epidemiol. 1982;116:385-393.
45. Mitchell BD, Kammerer CM, Blangero J, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp M, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans: the San Antonio Family Heart Study. Circulation. 1996;94:2159-2170.